BlackRock Health Sciences Trust has seen some strong performance recently, yet still trades at a -7.8% discount to NAV, offering compelling value. BME removed its options-writing strategy, eliminating ...
BlackRock Health Sciences Trust shares have declined 12.4% in the past year, underperforming the broader market rally. BME currently trades at an 8.3% discount to NAV, significantly wider than its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results